Patents matching “cells”

US 12428455

Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells

The Regents of the University of California · Granted Sep 30, 2025 · Expires Sep 25, 2045

US 12427170

Universal donor cells

CRISPR THERAPEUTICS AG · Granted Sep 30, 2025 · Expires Sep 25, 2045

US 12419955

Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus

Beijing Gene MINK Biotechnology CO.LTD · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12421316

Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells

The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12421517

Genetic modification of mammalian cells to confer resistance to CSF1R antagonists

The Regents of the University of California · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12421302

CAR-t cells and autoimmune diseases

The Regents of the University of California · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12414968

Compositions comprising bacterially derived minicells and methods of using the same

EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 16, 2025 · Expires Sep 11, 2045

US 12398373

Enhanced immune effector cells and use thereof

Fate Therapeutics, Inc. · Granted Aug 26, 2025 · Expires Aug 21, 2045

US 12391739

Method for producing gamma delta T cells

Takeda Pharmaceutical Company Limited · Granted Aug 19, 2025 · Expires Aug 14, 2045

US 12391923

SIRPα-silenced natural killer (NK) cells

The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

US 12383629

DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

US 12385013

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2025 · Expires Aug 7, 2045

US 12370256

Activation of resident memory T cells for the treatment of cancer

Regents of the University of Minnesota · Granted Jul 29, 2025 · Expires Jul 24, 2045

US 12371665

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Jul 29, 2025 · Expires Jul 24, 2045

US 12365875

Methods for generating skeletal muscle progenitor cells

The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

US 12365873

Methods for transducing immune cells

Allogene Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

US 12358968

Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

Providence Health & Services—Oregon · Granted Jul 15, 2025 · Expires Jul 10, 2045

US 12351824

Method for producing natural killer cells from pluripotent stem cells

Takeda Pharmaceutical Company Limited · Granted Jul 8, 2025 · Expires Jul 3, 2045

US 12344656

Genetically engineered T cells having improved persistence in culture

CRISPR THERAPEUTICS AG · Granted Jul 1, 2025 · Expires Jun 26, 2045

US 12344655

Gene-edited natural killer cells

CRISPR THERAPEUTICS AG · Granted Jul 1, 2025 · Expires Jun 26, 2045

US 12343448

Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

East China University of Science and Technology · Granted Jul 1, 2025 · Expires Jun 26, 2045

US 12343397

Drug-resistant immune cells and methods of use thereof

Regents of the University of Minnesota · Granted Jul 1, 2025 · Expires Jun 26, 2045

US 12338459

DNA-chimeric antigen receptor T cells for immunotherapy

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 24, 2025 · Expires Jun 19, 2045

US 12319740

Methods for production of tissue resident memory-like T cells and use thereof

The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045